Advertisement
Product › Details
murepavadin (POL7080)
Next higher product group | antibiotic | |
Status | 2013-11-04 development p2 existent | |
Organisation | Roche (Group) | |
Organisation 2 | Polyphor Ltd. (SIX: POLN) | |
Today | Spexis AG (SIX: SPEX) | |
Group | Spexis (Group) | |
Record changed: 2023-07-10 |
Advertisement
More documents for murepavadin (POL7080)
- [1] Polyphor Ltd.. (9/10/21). "Press Release: Polyphor and EnBiotix Announce Closing of Purchase Agreement of Inhaled Murepavadin by EnBiotix". Allschwil....
- [2] Polyphor Ltd.. (9/1/21). "Press Release: Polyphor and EnBiotix Announce Signing of Merger Agreement and Sale of Inhaled Murepavadin to EnBiotix". Allschwil....
- [3] Polyphor Ltd.. (5/9/19). "Press Release: Polyphor Temporarily Halts Enrollment in the Phase III Studies of Murepavadin for the Treatment of Patients with Nosocomial Pneumonia". Allschwil....
- [4] Polyphor Ltd.. (4/9/19). "Press Release: Polyphor Appoints Gökhan Batur as Chief Commercial Officer". Allschwil....
- [5] Polyphor Ltd.. (9/6/18). "Press Release: Polyphor Announces Financial Results for the First Half 2018". Allschwil....
- [6] Consilium Strategic Communications Ltd.. (7/17/18). "Press Release: Consilium Strategic Communications Advises Polyphor on its Successful CHF 155 Million (c. €130 Million) Fundraise and IPO on the SIX Swiss Exchange". London....
- [7] Polyphor Ltd.. (5/15/18). "Press Release: Polyphor Prices Its IPO at CHF 38 per Share and Lists on SIX Swiss Exchange [These materials may not be published, distributed or transmitted in the United States, Canada, Australia or Japan. ]"....
- [8] Reuters. (5/15/18). "News: Polyphor Prices IPO at 38 Sfr per Share". Zurich....
- [9] Polyphor Ltd.. (4/27/18). "Press Release: Polyphor Launches IPO on SIX Swiss Exchange and Sets Price Range [These materials may not be published, distributed or transmitted in the United States, Canada, Australia or Japan. ]"....
- [10] Polyphor Ltd.. (4/9/18). "Press Release: Polyphor Announces Plans to IPO and List on SIX Swiss Exchange [These materials may not be published, distributed or transmitted in the United States, Canada, Australia or Japan. ]"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top